HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study (Q44437254)
Jump to navigation
Jump to search
scientific article published on April 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study |
scientific article published on April 1, 2003 |
Statements
1 reference
HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study (English)
1 reference
Mounir Ait-Khaled
1 reference
Abdelrahim Rakik
1 reference
Philip Griffin
1 reference
Chris Stone
1 reference
Naomi Richards
1 reference
Deborah Thomas
1 reference
Judith Falloon
1 reference
Margaret Tisdale
1 reference
CNA2007 International Study Team
1 reference
1 April 2003
1 reference
1 reference
8
1 reference
2
1 reference
111-120
1 reference
Identifiers
1 reference